Mary Rensel, MD

Appointed
1998

Education & Fellowships

Fellowship - Cleveland Clinic
Neuroimmunology
Cleveland, OH USA
1998

Residency - Cleveland Clinic
Adult Neurology
Cleveland, OH USA
1995

Internship - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
1993

Medical Education - Medical College of Ohio at Toledo
Toledo, OH USA
1992

Undergraduate - Gannon University
Biology
Erie, PA USA
1988

Additional Training

• Quality as Value in Healthcare: What do current changes mean? 11/1/12
• Resonant Leadership: Creating Sustainable Leaders Through Mindfulness, Hope & Compassion, 9/11/12
• Middle East Cultural Competence: Culture, Patient Care and Working Relationships
• The Business of Healthcare, 10/12/11
• Foundations of Healthcare Communication for Physicians, 9/13/11
• Investigator Human Subject Research Education track 2/17/10
• Cleveland Clinic Staff Mentorship training 1/ 2010
• Palatucci Patient Advocacy training 1/2011
• Engaging Women Leaders: Setting Your Goals , 3/3/09
• The Science and Clinical Application of Integrative Holistic Medicine , San Diego, CA 11/16-21/08
• Using Sharepoint CCA 7/24/08
• Situational Leadership CCA 7/1/08
• Tools and Tips for Information Management , 10/21/08
• Patient Experience Within the Revenue Cycle, 11/25/08
• Writing Educational Objectives, Cleveland Clinic, 2006
• What the CEO Wants you to Know: Building Business Acumen, Physician Leadership University, Cleveland Clinic, 2006
• Process Improvement, Physician Leadership University, Cleveland Clinic, 2006
• Essentials of Clinical Teaching and Assessment Retreat, Cleveland Clinic, 2006
• Biostatics and Statistical Computing, Cleveland Clinic, 2002
• Research Methods Module I, Clinical Epidemiology, Cleveland Clinic, 2002
• Human Research Subjects Protection Training, Cleveland Clinic, 2002

Professional Highlights

• Network of Pediatric MS Centers Steering Committee
• Director of Pediatric MS,  Mellen Center
• Director of Wellness, Mellen Center
• Principal Investigator of Clinical trials
• President of Women's Professional Staff Association
• International Pediatric MS Study Group 2011- Present

Certifications

• Neurology

Specialty Interests

Adult Multiple Sclerosis, Pediatric Multiple Sclerosis, Pediatric NMO Wellness for MS patients, Integrative Medicine , NMO, Devics disease Clinical trials , Complementary Alternative Medicine

Awards & Honors

• College of Ohio Clinical Neurology Award 1992
• Alumni of the Year, St. Francis of Assisi 2003
• Distinguished Educator Level I Certificate awarded 2007
• Best Doctors of Cleveland 2010 -2013, Cleveland Magazine
• Caregiver Celebration Award 2013

Innovations & Patents

• BrainMAX

Memberships

• American Academy of Neurology, Fellow
• Diplomate, American Board of Psychiatry and Neurology
• Board Certification of the American Board of Integrative Holistic Medicine

See publications for Mary Rensel, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/3/2020, Dr. Rensel has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Rensel receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

• Sanofi Genzyme
• Multiple Sclerosis Association of America
• Biogen Idec, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.